Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04457544

Spontaneous Coronary Artery Dissection National Swiss Registry

Spontaneous coronary artery dissection (SCAD), is an underdiagnosed pathology, affecting predominantly young women without traditional cardiovascular risk factors and is associated with major adverse outcomes including myocardial infarction, cardiac arrest, or death.

Timely diagnosis of SCAD as well as clinical follow-up are of the essence in this pathology associated with major cardiac adverse outcomes. Despite recent improvements in diagnosis and recognition of the importance of SCAD, it remains poorly studied and understood.

In this context, we designed the SwissSCAD registry, a large, observational, prospective, cohort study, to describe the natural history of SCAD, its outcomes and its treatments.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Geneva University Hospitals

Geneva, 1205, Switzerland

Location status: Recruiting

Location contact

Sophie Degrauwe, MD

CONTACT

[email protected]

Véronique Menoni

CONTACT

[email protected]

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject is ≥18 years of age.
  • Patient presenting newly diagnosed SCAD or diagnosed with SCAD within the last 5 years.
  • Subject must be willing to sign a Patient Informed Consent (PIC).

Exclusion criteria

  • Patient unwilling or unable to provide informed consent.
  • Patients with atherosclerotic or iatrogenic coronary dissection.

Treatment and study plan

Primary outcomes

  1. Incidence of safety events at 30 days

    Time frame: 30 days

    Incidence of Major cardiovascular outcomes (MACE) at 30 days

Secondary outcomes

  1. Incidence of safety events at 1 year

    Time frame: 1 year

    Incidence of Major cardiovascular outcomes (MACE) at 1 year

  2. Incidence of safety events at 5 years

    Time frame: 5 years

    Incidence of Major cardiovascular outcomes (MACE) at 5 years

Study contacts

Contact information is provided by the study sponsor or research team.

Sophie Degrauwe, Dr

CONTACT

[email protected]

+41795530294

Veronique Menoni, PhD

CONTACT

[email protected]

+41795530917

Sponsors and collaborators

Lead sponsor

Dr. Sophie Degrauwe

Other

Registry information

Official study title

Spontaneous Coronary Artery Dissection (SCAD) National Swiss Registry (SwissSCAD)

Acronym: SwissSCAD

Important dates

Study start
2020
Primary completion
2025
Study completion
2030
First posted
Jul 7, 2020
Registry last updated
Nov 16, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.